You are now leaving jnj.com. We continue to build a pipeline of innovative biologic and oral therapies in core disease areas: rheumatoid arthritis, inflammatory bowel diseases and psoriasis. We are deeply committed to patients with these conditions and to the healthcare professionals and loved ones who care for them. Follow Linda A. Johnson at https://twitter.com/LindaJ—onPharma, 24/7 coverage of breaking news and live events. Learn about our commitment to helping patients obtain appropriate access to our medicines. But sales of medical devices and diagnostic equipment such as surgical tools and hip replacements fell 3.6% to $6.15 billion. Your use of the information on this site is subject to the terms of our Legal Notice. Ortho-Gynol was introduced in 1931 as the first prescription family planning product from the Ortho Products operating unit. Pulmonary hypertension refers to high blood vessel pressure in the lungs, and PAH is a rare, progressive form of this often-debilitating condition. Citi Research analyst Joanne Wuensch wrote to investors that the vaccine study pause should not overshadow the better-than-expected results, particularly in medical devices. EEO Is the Law | EEO Is the Law GINA Supplement | Do Not Sell My Personal Information. Turn on desktop notifications for breaking stories about interest? To get there, we’re focused on developing solutions that prolong and improve patient lives. Established in celebration of the legacy of “Dr. We are actively developing treatments for our patients in six important therapeutic areas: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology and Pulmonary Hypertension. To get there, we're focusing on transformational science that will allow patients to live longer and better lives. Johnson and Johnson is a major international pharmaceutical company. Johnson & Johnson is a long standing company that makes everything from baby products to personal hygiene products for consumers. While the disease affects more women than men, it can also develop in children of any age and across all ethnicities. Our prescription products serve patients across therapeutic areas that include cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience and pain, and oncology. That deal is expected to help the company expand its position in creating drugs that treat autoimmune diseases in which the immune system attacks cells and body tissue, including common chronic disorders such as rheumatoid arthritis and colitis. From the beginning of the pandemic, hospitals in hotspots canceled scheduled surgeries and many patients postponed care and avoided hospitals for fear of catching the virus. HALDOL® (haloperidol) was discovered by Janssen Pharmaceutica, N.V. in 1960. Our mission is to reduce the burden, disability and devastation caused by serious neuro psychiatric diseases and pain conditions. Johnson & Johnson posted revenue of $21.08 billion in the quarter. The company operates through three business segments, including Consumer; Pharmaceutical and Medical Devices; and Diagnostics. "Most of our brands are back to or above pre-COVID rates," said Jennifer Taubert, head of J&J's pharmaceutical business, adding that J&J's customers — hospitals, clinics and doctor practices — are “learning how to use a combination of teleheath and in-person visits.”. J&J beats 3Q net views, hikes 2020 forecast, but shares fall, 'A deep sickness': Former Republican strategist sounds off on 'Trumpism', Scrubs brand under fire for 'insensitive' ad featuring female physician, How to watch ABC News' Joe Biden town hall, Man who recently ran for governor arrested for murder of 12-year-old girl, FILE - This Sept. 13, 2016, file photo, shows Johnson & Johnson Band-Aid brand bandages in Surfside, Fla. Higher prescription drug sales and lower costs for litigation drove up Johnson & Johnson's fourth-quarter profit by 32%. ON NOW. Pulmonary hypertension refers to high blood vessel pressure in the lungs, and PAH is a rare, progressive form of this often-debilitating condition. The site you’re being redirected to is a branded pharmaceutical website. Sales of that equipment often indicates how busy hospitals are. The research priorities of our Neuroscience Therapeutic Area include Alzheimer’s Disease, Mood Disorders and Schizophrenia. We introduced a cell line technology that enables faster and most cost effective discovery, development and production of a range of potentially transformational vaccines and monoclonal antibodies. Despite the coronavirus pandemic hurting sales of most of its products, Johnson & Johnson boosted revenue slightly and doubled its third-quarter profit, mainly due to a huge litigation charge in the year-ago quarter. Our understanding of the complex pathways and molecular mechanisms of PAH has enabled us to develop tailored medicines to improve patient outcomes and make a difference for people around the world living with this disorder. We continue to seek and develop the next generation of transformational cardiovascular & metabolic therapies. Please click below to continue to that site. Explore Janssen’s innovative medical research & pharmaceutical product development practices to see how Janssen is creating a future where disease is a thing of the past. At Johnson & Johnson Inc., our mission is to enrich the health and wellness of every Canadian, every day. Through our ongoing efforts in discovery, biomarkers, clinical research and external innovation, we are poised for continued leadership and growth, bringing transformational medicines to patients and healthcare professionals around the world. To achieve this, we will translate internal and external science to deliver products that treat, cure, intercept, and prevent immune-mediated diseases. Adjusted net income was $5.87 billion, or $2.20 per share. Paul” and in recognition of current researchers demonstrating a similar spirit, the Dr. Paul Janssen Award was first presented in 2006. Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field. Johnson & Johnson Family of Companies have more than 265 operating companies in more than 60 countries employing approximately 126,500 … It raised its financial forecast for the year. The company forecast revenue in the range of $81.2 billion to $82 billion, up from $79.9 billion to $81.4 billion. J&J reported that sales of its prescription drugs jumped 5% to $11.42 billion — just over half its entire revenue and the second quarter in a row for that business to top $11 billion in revenue. Learn More "We Have a Health Disparities Problem in America": Meet a Woman on a Mission to Improve Healthcare for Black Women "We Have a Health Disparities Problem in America": Meet a Woman on a Mission to Improve Healthcare for Black Women. Ortho Diagnostic Systems introduces RhoGAM Rho(D) immune globulin, the first medication developed to prevent Rh hemolytic disease of the newborn. In 2019, among its top pharmaceutical drugs was Remicade which earned 4.38 billion U.S. dollars in sales for the company… With advanced biologic and other treatments, Janssen is investing in a transformative future, changing the way diseases are prevented, intercepted, treated and cured. We focus on finding and developing truly transformational therapies that target underlying disease pathways, important pathways, and novel mechanisms of action. For almost two decades, Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson, has been working to fundamentally change the way pulmonary arterial hypertension (PAH) is treated. But its stock price still tumbled Tuesday, amid a decline in broader markets and news that J&J had to temporarily pause all its COVID vaccine studies, including the huge, late-stage study pivotal to approval of its vaccine, “due to an unexplained illness in a study participant.”. The world's biggest maker of health care products on Wednesday, July 15, 2020, reported net income rose nearly $1 billion, to $4.01 billion, or $1.50 per share. We are committed to delivering targeted therapies to fight the devastation of cancer. We will do this by discovering and developing transformational therapies and vaccines that prevent, treat and cure some of the world’s most life-threatening infectious diseases such as HIV, viral hepatitis, respiratory syncytial virus, influenza and Ebola. We strive to discover and develop novel therapeutics and vaccines to treat and cure infectious diseases worldwide, improving treatment outcomes and patients’ lives. J&Js on Tuesday reported net income of $3.55 billion, or $1.33 per share, up 103% from $1.75 billion, or 66 cents per share, in 2019's third quarter. Our deep scientific expertise and demonstrated clinical development capabilities support our commitment to aggressively develop and launch transformational therapies for patients with cardiovascular and metabolic diseases. 18 of our prescription medicines are on the World Health Organization’s list of Essential Medications. Edward Jones analyst Ashtyn Evans kept her “Buy” rating on J&J shares, noting that she likes the company’s "diversification and the defensive nature of its product portfolio.". “We remain confident heading into 2021,” Chief Financial Office Joe Wolk told analysts on a conference call to discuss the results. Johnson & Johnson Pharmaceutical Products Showing all 13 results Default sorting Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low PROCRIT®, approved by the U.S. FDA for use in 1989, is a prescription medicine used to treat certain types of anemia. AdVac® technology, based on the development and production of adenovirus vectors is introduced. FILE - This Sept. 13, 2016, file photo, shows Johnson & Johnson Band-Aid brand bandages in Surfside, Fla. Higher prescription drug sales and lower costs for litigation drove up Johnson & Johnson… Behind every one of our brands is a tradition of innovative research, cutting-edge technology, and a deep commitment to delighting our consumers with products that they can trust for their entire family. Such pauses are not unusual in big studies, and it's unknown whether the participant — one of up to 60,000 planned for the global “ENSEMBLE” study — got J&J's shot or a placebo. The company operates in three business segments: Consumer, Pharmaceutical, and Medical Devices. The world’s biggest maker of health care products blew past Wall Street expectations, saying its sales were recovering sooner than expected as people started getting delayed care.